Jul 16, 2026· Comment from Center for Biological Diversity· FDA-2025-P-5437-0006
Filed as an attachment.
FDANonrulemakingFDA-2025-P-5437
Requests that the FDA revisit the approval of the Abbreviate New Drug Application 216616, a generic version of Mifepristone, to requires the inclusion of a provision in all Prescriber Requirements that a Catch-Kit and Red Medical Waste Bag be included with Mifepristone Prescriptions
RIN
—
Last modified
Oct 17, 2025
Comment window
—
Center for Biological Diversity filings
1
Activity
Center for Biological Diversity filed 1 comment on this docket between Jul 16, 2026 and Jul 16, 2026. 1 other organizations filed here.
What Center for Biological Diversity filed (1)
Abstract
Open
View on regulations.gov →Co-filers (1)
See everyone who commented →- Center for Biological DiversityTHIS ORG1 filing · confidence 97%
- Guttmacher Institutetrade assoc.1 filing · confidence 85%